# Blue Practice Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/blue-practice-co

- Industry: Medical Devices & Equipment
- Headquarters: Tokyo, Japan
- Website: www.bluepractice.co.jp/
- Total disclosed funding: $0.8M
- Latest round: Series A (Aug 28, 2020)
- Investors on record: 1

## About

Based in Tokyo, Japan and founded in 2019, Blue Practice Co., Ltd. is a biotechnology start-up company developing a blood vessel model mainly for surgery simulation and medical device evaluations. Blue Practice’s CEO and president is Koji Suzuki, who studied medical systems through the Executive Management Programme at the University of Tokyo, subsequently deciding to embark on his new business in the healthcare industry and establishing Blue Practice in 2019. Before then, his career path was mainly focused on the IT industry. Blue Practice was founded as a start-up company by Ohta Lab, Institute of Fluid Science, Tohoku University, and Haga Lab, Graduate School of Biomedical Engineering, Tohoku University, along with the Impulsing Paradigm Change Disruptive Technologies Program(ImPACT) from the Cabinet Office. In August 2020, the company received a fund of JPY 80 million from Tohoku University Venture Partners Co., Ltd. 

The company’s prime solution is its human blood vessel model, which can accurately reproduce the thickness, friction and the dynamic viscoelastic property of human blood vessels. Its model is used for a range of purposes such as medical training, treatment simulation and medical device evaluations. The company’s three main products are ORTA, which is a vascular treatment training model, a vascular treatment simulation package and a medical device test package.

## Funding rounds

- Series A, Aug 28, 2020, $0.8M — TOHOKU University Venture Partners

## Investors

- TOHOKU University Venture Partners (https://capitalatlas.ai/funds/tohoku-university-venture-partners) — Series A